Trial intelligence / Profile preview

Phase III randomized double-blind placebo-controlled trial of Shanjinlian Soft Capsules for common cold (wind-heat syndrome)

CTR20241345Phase 3Completed

Sponsor
Huanghe Traditional Chinese Medicine
Start
May 2024
Countries
1
01

Overview

A Phase 3 trial of Shanjinlian Soft Capsules in nasopharyngitis, sponsored by Huanghe Traditional Chinese Medicine. Started May 2024; status: completed.

02

Drugs

Shanjinlian Soft Capsules
03

Conditions

nasopharyngitis

Beyond the preview

Go deeper on CTR20241345.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20241345.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call